Answers are grounded in this paper and cite their sources.
Objectives The gut metabolome of colorectal cancer (CRC) patients remains inadequately characterized. This study aimed to compare fecal short-chain fatty acid (SCFA) and secondary bile acid levels between patients with CRC and normal subjects. Materials and Methods Stool specimens were collected from patients with CRC and normal individuals. Fecal samples were extracted with isopropanol: acetonitrile:water (3:2:2 ratio), derivatized with ethyl chloroformate, and were separated and analyzed for acetate, propionate, butyrate, lithocholic acid (LCA), and deoxycholic acid (DCA) by gas chromatography–mass spectrometry. Calibration curves were established with reference standard solutions. Compounds were identified by running the raw data through the National Institute of Standards and Technology mass spectral library. Clinical details were obtained from medical records. Statistical analysis Statistical analyses were performed using the Statistical Package for the Social Sciences version 29. Statistical significance was assessed using Pearson’s Chi-square, Mann–Whitney U, or Kruskal–Wallis tests. P < 0.05 was considered statistically significant. Results Higher levels of LCA and DCA were detected in the stool specimens of patients with CRC compared with the normal controls (median 3.56 vs. 1.67 pmol/kg, P < 0.001). The acetate, propionate, and butyrate levels did not significantly differ between the groups. The ratio of SCFAs to secondary bile acids was lower in the stool of patients with CRC than in the controls (median 20.64 vs. 49.61, P < 0.001). Conclusions A positive association between fecal LCA and DCA levels and CRC was observed in our cohort. These findings have implications for non-invasive screening and treatment of CRC.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: